Cargando…

Rational targeted therapeutics for double-hit lymphoma

“Double-hit lymphomas with MYC and BCL2 translocations can be effectively treated by combined targeting of the driver oncogenes”.

Detalles Bibliográficos
Autores principales:	Azizian, Nancy G, Liu, Yuanhui, Pham, Lan V, Li, Yulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912852/ https://www.ncbi.nlm.nih.gov/pubmed/31850145 http://dx.doi.org/10.2217/ijh-2019-0009

Ejemplares similares

Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma
por: Liu, Yuanhui, et al.
Publicado: (2019)

Advancing the management of double hit lymphoma
por: Landsburg, Daniel J.
Publicado: (2017)

Altered pathways and targeted therapy in double hit lymphoma
por: Zhuang, Yuxin, et al.
Publicado: (2022)

BFL-1 expression determines the efficacy of venetoclax in MYC+/BCL2+ double hit lymphoma
por: Esteve-Arenys, Anna, et al.
Publicado: (2018)

mTOR inhibition attenuates chemosensitivity through the induction of chemotherapy resistant persisters
por: Liu, Yuanhui, et al.
Publicado: (2022)

Drug therapy for double-hit lymphoma
por: Phuoc, Vania, et al.
Publicado: (2019)

De Novo CD5-Positive Primary Gastric Diffuse Large B-Cell Lymphoma Coexpressing MYC and BCL6: Towards a Proper Subset of Double-Hit, Triple-Hit and, Maybe, Quadruple-Hit B-Cell Lymphomas?
por: Roncati, Luca
Publicado: (2018)

Tolosa-Hunt Syndrome in Double-Hit Lymphoma
por: Peddi, Prakash, et al.
Publicado: (2015)

Targeting MYC and BCL2 by a natural compound for “double‐hit” lymphoma
por: Liu, Xiaoqian, et al.
Publicado: (2022)

Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma
por: Feng, Liying, et al.
Publicado: (2022)

Double hit mouse model of Parkinson's disease
por: Schirinzi, Tommaso, et al.
Publicado: (2016)

Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells
por: Du, Rong, et al.
Publicado: (2021)

Flow Cytometric Evaluation of Double/Triple Hit Lymphoma
por: Roth, Christine G., et al.
Publicado: (2016)

XPO1-dependent nuclear export as a target for cancer therapy
por: Azizian, Nancy G., et al.
Publicado: (2020)

Rational Prediction with Molecular Dynamics for Hit Identification
por: Nichols, Sara E, et al.
Publicado: (2012)

Hitting the Bullseye: Are extracellular vesicles on target?
por: Noren Hooten, Nicole, et al.
Publicado: (2020)

Double-hit lymphoma of the male breast: a case report
por: Elgaafary, Shaymaa, et al.
Publicado: (2020)

Establishment and characterization of a novel MYC/BCL2 “double-hit” diffuse large B cell lymphoma cell line, RC
por: Pham, Lan V., et al.
Publicado: (2015)

Diagnostic Approach for Double-Hit and Triple-Hit Lymphoma Based on Immunophenotypic and Cytogenetic Characteristics of Bone Marrow Specimens
por: Kim, Heyjin, et al.
Publicado: (2020)

Peripheral immune cell profiling of double-hit lymphoma by mass cytometry
por: Lei, Tao, et al.
Publicado: (2023)

Clinical Significance of “Double-hit” and “Double-protein” expression in Primary Gastric B-cell Lymphomas
por: He, Miaoxia, et al.
Publicado: (2016)

Big Hits
por: Wojtys, Edward M.
Publicado: (2009)

Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy
por: Zhang, Jingcheng, et al.
Publicado: (2020)

Rational Design of Hit Compounds Targeting Staphylococcus aureus Threonyl-tRNA Synthetase
por: Rybak, Mariia Yu., et al.
Publicado: (2021)

Do Patient Education Materials in Sleep Apnea Hit the Target?
por: Jamil, Shazia M.
Publicado: (2022)

Hit Early and Hit Hard in Pulmonary Arterial Hypertension? Not So Fast!
por: Hassoun, Paul M., et al.
Publicado: (2021)

Ataxia's double hit
por: Leslie, Mitch
Publicado: (2010)

Cutaneous presentation of Double Hit Lymphoma: A Case Report With Review of the Literature
por: Khelfa, Yousef, et al.
Publicado: (2016)

Clinical Features and Immunophenotypes of Double-Hit Diffuse Large B-Cell Lymphoma
por: Wu, Cheng-Han, et al.
Publicado: (2022)

Hitting children is wrong
por: Waterston, Tony, et al.
Publicado: (2020)

Transformation of double-hit follicular lymphoma to plasmablastic lymphoma: a partial role of MYC gene rearrangement
por: Ise, Mikiko, et al.
Publicado: (2018)

Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma
por: Huang, Sixia, et al.
Publicado: (2019)

Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
por: Li, Weiping, et al.
Publicado: (2019)

Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility
por: Craig, Jeffrey W., et al.
Publicado: (2018)

Establishment and characterization of a novel ‘double‐hit’ follicular lymphoma cell line, FL‐SJC
por: Chen, Min, et al.
Publicado: (2020)

Drug and therapeutics committees as guardians of safe and rational medicines use
por: Sofat, Reecha, et al.
Publicado: (2019)

Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy
por: Galati, Giovanni, et al.
Publicado: (2016)

Unusual presentation of extra-nodal double-hit follicular lymphoma: a case report
por: Lazzi, Stefano, et al.
Publicado: (2022)

P1674: CLINICAL IMPACT OF NON-ADHERENCE TO HIT GUIDELINES: A DOUBLE HIT IN HIT
por: Al Raizah, A., et al.
Publicado: (2022)

Hit a new high
por: Zhuo, Min, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_3pp9pjnroff67j7m8i4vb2668q